These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29878370)

  • 1. Comparative outcomes of adenosquamous carcinoma of the pancreas: An analysis of the National Cancer Database.
    Hester CA; Augustine MM; Choti MA; Mansour JC; Minter RM; Polanco PM; Porembka MR; Wang SC; Yopp AC
    J Surg Oncol; 2018 Jul; 118(1):21-30. PubMed ID: 29878370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical presentation and prognosis of adenosquamous carcinoma of the pancreas - Matched-pair analysis with pancreatic ductal adenocarcinoma.
    Kaiser J; Hinz U; Mayer P; Hank T; Niesen W; Hackert T; Gaida MM; Büchler MW; Strobel O
    Eur J Surg Oncol; 2021 Jul; 47(7):1734-1741. PubMed ID: 33622577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Tumor Location on Resection and Survival for Pancreatic Ductal Adenocarcinoma.
    Winer LK; Dhar VK; Wima K; Morris MC; Lee TC; Shah SA; Ahmad SA; Patel SH
    J Surg Res; 2019 Jul; 239():60-66. PubMed ID: 30802706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Outcome and Prognostic Factors of Pancreatic Adenosquamous Carcinoma Compared to Ductal Adenocarcinoma-Results from the German Cancer Registry Group.
    Braun R; Klinkhammer-Schalke M; Zeissig SR; Kleihus van Tol K; Bolm L; Honselmann KC; Petrova E; Lapshyn H; Deichmann S; Abdalla TSA; Heckelmann B; Bronsert P; Zemskov S; Hummel R; Keck T; Wellner UF
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 415 patients with adenosquamous carcinoma of the pancreas: a population-based analysis of prognosis and survival.
    Boyd CA; Benarroch-Gampel J; Sheffield KM; Cooksley CD; Riall TS
    J Surg Res; 2012 May; 174(1):12-9. PubMed ID: 21816433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of adenosquamous carcinoma of the pancreas: a matched case-control study.
    Imaoka H; Shimizu Y; Mizuno N; Hara K; Hijioka S; Tajika M; Kondo S; Tanaka T; Ogura T; Obayashi T; Hasegawa T; Niwa Y; Yamao K
    Pancreas; 2014 Mar; 43(2):287-90. PubMed ID: 24518509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological features and surgical outcomes of adenosquamous carcinoma of the pancreas: a retrospective analysis of patients with resectable stage tumors.
    Komatsu H; Egawa S; Motoi F; Morikawa T; Sakata N; Naitoh T; Katayose Y; Ishida K; Unno M
    Surg Today; 2015 Mar; 45(3):297-304. PubMed ID: 24973941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of the proliferative ability of the squamous component regarding tumor progression of adenosquamous carcinoma of the pancreas: A preliminary report.
    Hoshimoto S; Hoshi N; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Wakamatsu S; Hoshi S; Hirabayashi K; Ogata Y
    Pancreatology; 2017; 17(5):788-794. PubMed ID: 28784574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraductal papillary mucinous neoplasms of the pancreas with concurrent pancreatic and periampullary neoplasms.
    Sahora K; Crippa S; Zamboni G; Ferrone C; Warshaw AL; Lillemoe K; Mino-Kenudson M; Falconi M; Fernandez-del Castillo C
    Eur J Surg Oncol; 2016 Feb; 42(2):197-204. PubMed ID: 26687069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival after resection for invasive intraductal papillary mucinous neoplasm and for pancreatic adenocarcinoma: a multi-institutional comparison according to American Joint Committee on Cancer Stage.
    Waters JA; Schnelldorfer T; Aguilar-Saavedra JR; Chen JH; Yiannoutsos CT; Lillemoe KD; Farnell MB; Sarr MG; Schmidt CM
    J Am Coll Surg; 2011 Aug; 213(2):275-83. PubMed ID: 21601488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Outcomes of Adenosquamous Carcinoma of the Gallbladder: an Analysis of the National Cancer Database.
    Murimwa G; Hester C; Mansour JC; Polanco PM; Porembka MR; Wang SC; Zeh HJ; Yopp AC
    J Gastrointest Surg; 2021 Jul; 25(7):1815-1827. PubMed ID: 32705618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological mutational signature in adenosquamous cancer of pancreas: an exploratory study of potentially therapeutic targets.
    Silvestris N; Brunetti O; Pinto R; Petriella D; Argentiero A; Fucci L; Tommasi S; Danza K; De Summa S
    Expert Opin Ther Targets; 2018 May; 22(5):453-461. PubMed ID: 29561217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A matched-cohort analysis of 192 pancreatic anaplastic carcinomas and 960 pancreatic adenocarcinomas: A 13-year North American experience using the National Cancer Data Base (NCDB).
    Paniccia A; Hosokawa PW; Schulick RD; Henderson W; Kaplan J; Gajdos C
    Surgery; 2016 Aug; 160(2):281-92. PubMed ID: 27085687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does adjuvant therapy improve overall survival for stage IA/B pancreatic adenocarcinoma?
    Ostapoff KT; Gabriel E; Attwood K; Kuvshinoff BW; Nurkin SJ; Hochwald SN
    HPB (Oxford); 2017 Jul; 19(7):587-594. PubMed ID: 28433254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?
    Konstantinidis IT; Warshaw AL; Allen JN; Blaszkowsky LS; Castillo CF; Deshpande V; Hong TS; Kwak EL; Lauwers GY; Ryan DP; Wargo JA; Lillemoe KD; Ferrone CR
    Ann Surg; 2013 Apr; 257(4):731-6. PubMed ID: 22968073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic and Epigenomic Landscaping Defines New Therapeutic Targets for Adenosquamous Carcinoma of the Pancreas.
    Lenkiewicz E; Malasi S; Hogenson TL; Flores LF; Barham W; Phillips WJ; Roesler AS; Chambers KR; Rajbhandari N; Hayashi A; Antal CE; Downes M; Grandgenett PM; Hollingsworth MA; Cridebring D; Xiong Y; Lee JH; Ye Z; Yan H; Hernandez MC; Leiting JL; Evans RM; Ordog T; Truty MJ; Borad MJ; Reya T; Von Hoff DD; Fernandez-Zapico ME; Barrett MT
    Cancer Res; 2020 Oct; 80(20):4324-4334. PubMed ID: 32928922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN).
    McMillan MT; Lewis RS; Drebin JA; Teitelbaum UR; Lee MK; Roses RE; Fraker DL; Vollmer CM
    Cancer; 2016 Feb; 122(4):521-33. PubMed ID: 26587698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic Features and Outcomes of Early-Onset Pancreatic Adenocarcinoma in the United States.
    Ordonez JE; Hester CA; Zhu H; Augustine M; Porembka MR; Wang SC; Yopp AC; Mansour JC; Zeh HJ; Polanco PM
    Ann Surg Oncol; 2020 Jun; 27(6):1997-2006. PubMed ID: 31894482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved long-term outcomes after resection of pancreatic adenocarcinoma: a comparison between two time periods.
    Serrano PE; Cleary SP; Dhani N; Kim PT; Greig PD; Leung K; Moulton CA; Gallinger S; Wei AC
    Ann Surg Oncol; 2015 Apr; 22(4):1160-7. PubMed ID: 25348784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical outcome of adenosquamous carcinoma of the pancreas.
    Okabayashi T; Hanazaki K
    World J Gastroenterol; 2008 Nov; 14(44):6765-70. PubMed ID: 19058301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.